Medigene (Germany)
In research, Medigene (Germany) stands highest in Life Sciences (#8,284 of 14,347 worldwide), over all time.
- World rank, 2022–2025
- #20,776 of 28,054 · #18,650 all time
- Rank in Germany
- #811 of 1,178
- Research works
- 350 ▲ 113% vs 2013–17
- Citations
- 7.8k 22.2 per fractional work
- Top-10% rate
- 10.6% record average 16.5%
- Open access
- 47% world 28%
What is Medigene (Germany) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #8,284 of 14,347 | 21.5% | 134 |
Each strip is that field’s whole ranked pool, with the notch where Medigene (Germany) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.2×. Every wedge is a field page.
- Immunology and Microbiology 5.2×
- Biochemistry, Genetics and Molecular Biology 3.3×
- Medicine 1.8×
- Arts and Humanities 1.8×
- Economics, Econometrics and Finance 1.6×
- Psychology 1.2×
- Health Professions 0.9×
- Social Sciences 0.9×
- Business, Management and Accounting 0.9×
- Mathematics 0.8×
- Earth and Planetary Sciences 0.7×
- Environmental Science 0.6×
- Nursing 0.5×
- Decision Sciences 0.5×
- Chemistry 0.4×
- Neuroscience 0.4×
- Energy 0.4×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Physics and Astronomy 0.3×
- Computer Science 0.2×
- Agricultural and Biological Sciences 0.2×
- Engineering 0.1×
- Materials Science 0.0×
Which keywords describe research at Medigene (Germany)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Tumor Regression, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Tumor Microenvironment and Immune Checkpoint Blockade.
- Tumor Targeting
- Nutrition Transition
- Mobile Health
- Cancer Genomics
- Stakeholder Engagement
- Rituximab
- Gene Therapy
- PET Imaging
- Antibody Engineering
- Targeted Therapy
- Vaccine Adjuvants
- Glycosylation
- Immunity
- Cancer Therapy
- Innate Immunity
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Chimeric Antigen Receptor
- Lymphoma
- Immunotherapy
- Cancer Immunotherapy
- Tumor Regression
- CAR T Cells
- Tumor Microenvironment
- Inflammation
- Antigen Presentation
- Cancer
- Monoclonal Antibodies
- Dendritic Cells
- Tumor Antigen
- Identity
- Therapeutic Antibodies
- Fc Receptors
- Angiogenesis
- Precision Medicine
- Governance
- Therapeutic Targets
- Indigenous Populations
- Mutational Signatures
- Public Administration
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer Immunotherapy7▲ 64×2 topics
- Immunotherapy7▲ 12×7 topics
- Tumor Regression6▲ 76×2 topics
- Lymphoma6▲ 50×2 topics
- CAR T Cells5▲ 95×1 topic
- Chimeric Antigen Receptor5▲ 95×1 topic
- Tumor Microenvironment4▲ 10×4 topics
- Immune Checkpoint Blockade3▲ 37×1 topic
- Inflammation3▲ 1.92×19 topics
- PD-1 and PD-L13▲ 37×1 topic
- Antigen Presentation2▲ 36×2 topics
- Innate Immunity2▲ 9.9×3 topics
- Cancer2▲ 2.3×14 topics
- Cancer Therapy2▲ 5.4×10 topics
- Monoclonal Antibodies2▲ 34×3 topics
- Immunity2▲ 7.3×2 topics
- Dendritic Cells2▲ 31×2 topics
- Glycosylation2▲ 24×3 topics
- Tumor Antigen2▲ 44×1 topic
- Vaccine Adjuvants2▲ 44×1 topic
- Identity2▲ 3.5×8 topics
- Targeted Therapy2▲ 10×3 topics
- Therapeutic Antibodies2▲ 33×2 topics
- Antibody Engineering2▲ 39×1 topic
- Fc Receptors2▲ 39×1 topic
- PET Imaging2▲ 13×3 topics
- Angiogenesis2▲ 6.2×6 topics
- Gene Therapy2▲ 11×3 topics
- Precision Medicine2▲ 4.5×3 topics
- Rituximab2▲ 14×2 topics
- Governance1▲ 5.7×3 topics
- Stakeholder Engagement1▲ 20×2 topics
- Therapeutic Targets1▲ 12×3 topics
- Cancer Genomics1▲ 22×1 topic
- Indigenous Populations1▲ 107×1 topic
- Mobile Health1▲ 12×3 topics
- Mutational Signatures1▲ 22×1 topic
- Nutrition Transition1▲ 48×1 topic
- Public Administration1▲ 18×2 topics
- Tumor Targeting1▲ 8.7×3 topics
Which research topics does Medigene (Germany) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 5 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 3 Immunotherapy and Immune Responses Immunology 2 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
- 5 Indigenous Health and Education General Health Professions 1 works
- 6 Cancer Genomics and Diagnostics Cancer Research 1 works
- 7 Corporate Social Responsibility and Sustainability Organizational Behavior and Human Resource Management 1 works
- 8 Cancer Research and Treatments Biotechnology 1 works
- 9 Advanced Biosensing Techniques and Applications Molecular Biology 1 works
- 10 Global Economic and Social Development Economics and Econometrics 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Medigene (Germany)'s research output changed?
Output in 2018–2022 was 113% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Planegg
- Urologische Klinik München
- MorphoSys (Germany)
- Müller BBM (Germany)
- Eisbach Bio (Germany)
- Dynamic Biosensors (Germany)
- advanceCOR (Germany)
- ResMed (Germany)
- Ethris (Germany)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.